Cite
MLA Citation
Mauro Boronat et al.. “Potential implications of the choice among three alternative treatment targets for apolipoprotein B100 in the management of patients with type 2 diabetes and chronic kidney disease.” Diabetes & vascular disease research, vol. 11, n.d., pp. 53–59. http://access.bl.uk/ark:/81055/vdc_100054465472.0x000012